At the time of writing, Sana Biotechnology Inc [SANA] stock is trading at $1.59, down -3.64%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SANA shares have lost -9.66% over the last week, with a monthly amount drifted -29.65%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on March 18, 2025, when Citizens JMP upgraded its rating to a Mkt Outperform but kept the price target unchanged to $5 for it. Previously, Jefferies started tracking the stock with Buy rating on March 14, 2025, and set its price target to $7. On January 08, 2025, upgrade upgraded it’s rating to Buy. JMP Securities downgraded its rating to a Mkt Perform. Rodman & Renshaw initiated its recommendation with a Buy and recommended $16 as its price target on June 26, 2024. H.C. Wainwright upgraded its rating to Buy for this stock on January 16, 2024, but kept the price target unchanged to $12. In a note dated September 25, 2023, JMP Securities initiated an Mkt Outperform rating and provided a target price of $9 on this stock.
For the past year, the stock price of Sana Biotechnology Inc fluctuated between $1.26 and $10.50. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $1.59 at the most recent close of the market. An investor can expect a potential return of 403.14% based on the average SANA price forecast.
Analyzing the SANA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.85 and Total Capital is -0.59. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5467 points at the first support level, and at 1.5033 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6767, and for the 2nd resistance point, it is at 1.7633.
Ratios To Look Out For
It is important to note that Sana Biotechnology Inc [NASDAQ:SANA] has a current ratio of 3.54. As well, the Quick Ratio is 3.54, while the Cash Ratio is 2.81.
Transactions by insiders
Recent insider trading involved CHRISTIAN HORDO & KATHARINE HO, Officer, that happened on Feb 18 ’25 when 75000.0 shares were purchased. Officer, CHRISTIAN HORDO & KATHARINE HO completed a deal on Jan 16 ’25 to buy 75000.0 shares. Meanwhile, See Remark 1 FMR LLC sold 0.29 million shares on Jan 08 ’25.
